As in prior models, PF promoted differentiation and suppressed stemness markers in CRC PDOs (Figure 3F); effects were again restricted to CDX2-low tumors, consistent with findings from CRC cell lines (Figure 2C) and xenografts (Figure 2K). The gene discussed is CDX2; the disease is colorectal carcinoma.